Association between REDUCE-IT criteria, coronary artery disease severity, and cardiovascular events: the Western Denmark Heart Registry.
Martin Bødtker MortensenOmar DzayeAlexander C RazaviJesper Møller JensenFlemming Hald SteffensenHans Erik BøtkerMiguel Cainzos-AchiricaHenrik Toft SorensenMichael MaengMichael J BlahaKhurram NasirBjarne Linde NørgaardPublished in: European journal of preventive cardiology (2022)
Atherosclerotic plaque burden as assessed by CAC can identify REDUCE-IT-eligible patients who are expected to derive most, and least, absolute benefit from treatment with icosapent ethyl regardless of obstructive versus non-obstructive CAD status.
Keyphrases
- coronary artery disease
- cardiovascular events
- end stage renal disease
- percutaneous coronary intervention
- coronary artery bypass grafting
- ejection fraction
- chronic kidney disease
- newly diagnosed
- cardiovascular disease
- heart failure
- peritoneal dialysis
- prognostic factors
- risk factors
- atrial fibrillation
- patient reported outcomes
- acute coronary syndrome
- aortic valve